Mike Baek, First Principles Capital Management
Doug Dachille, First Principles Capital Management (Co-Chair)
Ora Dar, Israeli Life Sciences Fund
Ansbert Gadicke, MPM Capital Management
Adam Klimek, J.P. Morgan
Pablo Legorreta, Royalty Pharma
Andrew Lo, MIT (Co-Chair)
Joseph Naggar, GoldenTree Asset Management
Averill L. Powers, Syzygy Therapeutics
Kira Rosoff, Deutsche Bank
Greg Simon, Poliwogg
Jake Xia, Morgan Stanley
Specific Questions to be Addressed
- What are realistic capital structures for megafunds?
- How will capital be raised? Who are the natural investors?
- What concerns will investors have and how can they be addressed?
- How does a megafund work with foundations and endowments?